Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
crispr
4
×
deals
4
×
editas medicine
4
×
life sciences
national blog main
boston blog main
cancer
clinical trials
national
national top stories
novartis
san francisco blog main
abbvie
allergan
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
crispr therapeutics
detroit blog main
detroit top stories
europe blog main
fda
indiana blog main
indiana top stories
ipo
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
rare diseases
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
startups
takeda pharmaceutical
What
bio
car
gene
medicines
roundup
abbvie
access
acquisitions
advanced
alliance
announced
bails
biotech
brand
bridgebio
capacity
capital
cell
ceo
collabs
consolidation
covid
crispr
daniel
deal
develop
drugs
editas
editing
emerges
exits
experimental
falcon
firm
focus
genetic
gilead
gilead’s
grab
headlines
Language
unset
Current search:
crispr
×
deals
×
" editas medicine "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
